NEWS
GE HEALTHCARE ADVANCES PRECISION CARE TO DELIVER NEXT- GENERATION DIGITAL IMAGING AND WORKFLOW SOLUTIONS receiving personalised care,” said Jean-Luc Procaccini, President and CEO, Molecular Imaging & Computed Tomography, GE HealthCare.“ We are committed to delivering technology that unifies data across systems and organisations, breaking down workflow barriers to help drive better clinical outcomes and elevate the standard of patient care.”
GE HealthCare has announced the combination of GE
HealthCare’ s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organisations boasting GE HealthCare systems alongside MIM software with MIM Encore, a cutting-edge, single platform design based on user input to help enhance diagnostic confidence, streamline workflows and support the future of personalised medicine.
“ Operational efficiency and seamless collaboration are not just goals – they’ re the cornerstone to success. That’ s why we aim to provide tools that can help enhance providers’ confidence in decision making and support patients in
NEW AI-POWERED SERVICE LAUNCHED TO TRANSFORM CANCER DETECTION AND CARE
new Artificial Intelligence-powered service designed to
A transform cancer research has been launched.
The service, which was funded by the NIHR, is the result of a partnership between The Royal Marsden NHS Foundation Trust; digital business and technology services firm NTT DATA; and CARPL. ai, an AI and Machine Learning platform.
It aims to develop new ways to speed up cancer detection and treatment across the NHS by using AI to analyse medical images. This will help support clinicians in making faster and more accurate decisions.
How the AI service works
The AI-powered radiology analysis service is designed to develop and evaluate the use of AI in medical imaging to improve the detection of cancers, including:
• Sarcoma
• Lung cancer
• Breast cancer
• Brain cancer
• Prostate cancer
The use of this technology will help to speed up response times and provide more accurate diagnoses and better-targeted treatments, ultimately improving outcomes for patients.
This service runs on a clinical imaging platform, built by NTT DATA in partnership with CARPL. ai. The new platform helps test and manage AI algorithms and includes a collection of AI models for analysing medical images.
Research teams at The Royal Marsden and the Institute of Cancer Research will be able to use the technology to test different AI models on various types of cancer scans and images in real clinical settings.
Professor Mike Lewis, NIHR Scientific Director for Innovation, said:“ This AI-powered service represents the cutting edge of cancer research and it is going to transform treatment, better support NHS staff and ultimately change patients’ lives. It is another great example of how NIHRfunded and supported research will ensure the best care is there when patients need it.”
6 www. intelligenthealth. tech